Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in ...

The United States is home to one of the leading healthcare systems globally, primarily due to its remarkable ability to drive ...

Toagosei Co (JP:4045) has released an update. Toagosei Co., Ltd. has invested 500 million yen in PeptiStar Inc., a company specializing in peptide ...

The Biden-Harris administration has stifled innovation and made it harder for new drugs to reach patients, write Vrushab ...

Naloxone is a life-saving medication which helps reverse the effects of an opioid overdose. Improving naloxone access is a central pillar of the federal response to the worsening opioid crisis in the ...

Design and digital innovation can play a vital role in renewing audiences’ trust in pharma brands and helping engage Gen Z ...

India IT Services players are more insulated now from such anti-immigration policies than they were in 2016. All players have ...

Howard Burnett, Vice President, Global Pulmonary Category, Aptar Pharma, stated, "The CHI team brings deep knowledge, experience and innovation to the dry powder inhaler landscape. Aptar Pharma is ...

On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...

Dr. Najiba Al Shezawy, Co-Chairman of AfriSummit, expressed her gratitude for the participation of African National ...

Revenue Exceed RMB30.9 Billion with R&D Expenditure RMB3.9 Billion Continuing to Consolidate its Dominant Position In The fields of Breast Cancer and Lung Cancer ...